Elevance Health Target Price

Analysts' average 12-month price target for Elevance Health is $450.

Get informed when a big investor buys or sells

+ Follow

Share Price

$424.24

Average Target Price

$452.00

6.5% upside

21 analysts in the last 4 months

High: $498 | Low: $393

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-17	Leerink Partners	$395	6.9% downside
2026-07-16	Bernstein	$488	15% upside
2026-07-16	Barclays	$457	7.7% upside
2026-07-16	Wells FargoStephen Baxter	$473	11.5% upside
2026-07-16	Guggenheim	$455	7.3% upside
2026-07-16	Robert W. Baird	$393	7.4% downside
2026-07-16	Goldman Sachs	$395	6.9% downside
2026-07-16	RBC Capital	$424	0.1% downside
2026-07-16	New Street	$482	13.6% upside
2026-07-14	Truist Financial	$475	12% upside
2026-07-13	Wells Fargo	$492	16% upside
2026-07-09	RBC CapitalBen Hendrix	$439	3.5% upside
2026-07-07	Raymond JamesSarah James	$450	6.1% upside
2026-07-02	Bernstein	$482	13.6% upside
2026-06-08	Mizuho Securities	$465	9.6% upside
2026-06-04	Morgan Stanley	$404	4.8% downside
2026-06-01	Truist FinancialDavid MacDonald	$450	6.1% upside
2026-05-26	BarclaysAndrew Mok	$480	13.1% upside
2026-05-22	UBS	$460	8.4% upside
2026-05-20	Deutsche Bank	$498	17.4% upside
2026-05-20	Mizuho Securities	$435	2.5% upside
2026-04-24	Barclays	$408	3.8% downside
2026-04-24	Guggenheim	$399	5.9% downside
2026-04-23	Leerink Partners	$364	14.2% downside
2026-04-23	Robert W. Baird	$331	22% downside
2026-04-20	JefferiesDavid Windley	$391	7.8% downside
2026-03-10	Mizuho SecuritiesAnn Hynes	$350	17.5% downside
2026-02-03	RBC Capital	$358	15.6% downside
2026-02-02	Truist Financial	$390	8.1% downside
2026-02-02	Piper Sandler	$409	3.6% downside
2026-02-02	Craig-Hallum	$409	3.6% downside
2026-02-01	Bernstein	$409	3.6% downside
2026-01-30	Wells Fargo	$391	7.8% downside
2026-01-30	Barclays	$393	7.4% downside
2026-01-29	UBS	$400	5.7% downside
2026-01-29	Deutsche Bank	$332	21.7% downside
2026-01-29	GuggenheimJason Cassorla	$396	6.7% downside
2026-01-22	GuggenheimJason Cassorla	$414	2.4% downside
2026-01-09	Mizuho SecuritiesAnn Hynes	$413	2.6% downside
2026-01-08	Wolfe ResearchJustin Lake	$425	0.2% upside
2026-01-07	Wells Fargo	$424	0.1% downside
2026-01-06	Bernstein	$431	1.6% upside
2026-01-05	BarclaysAndrew Mok	$404	4.8% downside
2025-12-19	Deutsche BankGeorge Hill	$320	24.6% downside
2025-12-18	Morgan Stanley	$352	17% downside
2025-11-03	Mizuho Securities	$400	5.7% downside
2025-10-22	Barclays	$385	9.2% downside
2025-10-21	Bernstein	$420	1% downside
2025-10-14	Goldman Sachs	$343	19.1% downside
2025-10-14	Truist Financial	$400	5.7% downside

Elevance Health (ELV) FAQ

Elevance Health (ELV) currently reports a target price of $450. Use the charts on this page to explore Elevance Health's target price history and peer comparisons.

Analysts' average 12-month price target for Elevance Health is $450, about 6.5% upside from the current share price of $424.24. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $450, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Elevance Health, and consider following ELV for alerts when major investors trade the stock.

Elevance Health is classified in the Finance sector. On target price, it currently shows $450. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing ELV with unrelated industries.